First-line Serplulimab in Metastatic Colorectal Cancer: Phase 2 Results of a Randomized, Double-Blind, Phase 2/3 Trial
Med(2024)
关键词
serplulimab,HLX04,bevacizumab,metastatic colorectal cancer,phase 2/3 trial
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要